Market Tracker

12/09 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

1.46
Delayed Data
As of 4:00pm ET
 +0.03 / +2.10%
Today’s Change
1.16
Today|||52-Week Range
8.95
-82.60%
Year-to-Date
How TETRA Technologies, Inc. (TTI) Stacks Up Against Its Peers
Dec 08 / Investing Channel - Paid Partner Content
The Worst Biotech Stocks of 2016
Dec 02 / MotleyFool.com - Paid Partner Content
Why Novavax Stock Crashed in November
Dec 06 / MotleyFool.com - Paid Partner Content
3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
Read This Before You Buy Biotech Stocks
Dec 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.43
Today’s open1.48
Day’s range1.41 - 1.54
Volume14,550,572
Average volume (3 months)15,641,352
Market cap$387.9M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-75.05%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
SYRSSyros Pharmaceutical...-0.03-0.18%
MCRBSeres Therapeutics I...+0.10+1.03%
PTGXProtagonist Therapeu...-0.91-3.97%
AGENAgenus Inc-0.05-1.15%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts